|
|
|
|
|
|
|
12.08.26 - 14:54
|
wikifolio-Trader Sebastian "Bastian24" Steyer: "Aktiv bedeutet nicht: Ständig hin und her" - Kandidaten: Hitachi, NXP, Aurubis (BRN)
|
|
|
"Auch wenn man gar nicht so viel aktiv an der Börse ist, kann man trotzdem gute Renditen erwirtschaften. Aktiv bedeutet nicht: Ständig hin und her." Sebastian Steyers wikifolio "Qualitätsaktien aktiv" ( https://go.brn-ag.de/242 ) funktioniert über Diversifikation und Korrelation. So ist zum Beispiel Nvidia deutlich höher gewichtet als Rheinmetall. 46 Aktien stecken derzeit im Depot, darunter Cash Cows wie Amazon, Alphabet oder Apple. "Seit Jahresbeginn sind wir bei 11,7 % Rendite. Unter den großen Gewinnern: Applied Materials, Roche, Taiwan Semiconductor, Equinor, United Utilities." Unter den Kauf- und Aufstockungskandidaten befinden sich Hitachi, Aurubis, Siemens und NXP Semiconductors. "Mich reizt das Thema Robotik. Aurubis ist ein deutscher Top Player in der Kupferindustrie. Bei Siemens mache ich mir überhaupt keine Sorgen. NXP ist ein Philips-Spin-Off sowie eine Top-Aktie mit relativ moderater Bewertung."...
|
|
|
|
|
|
|
|
|
12.08.26 - 13:12
|
Amcor Reports Net Income In Q4 (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Amcor (AMCR) reported fourth quarter net income of $389 million compared to a loss of $39 million prior-year. Profit per share was $0.83 compared to a loss of $0.10. Adjuste......
|
|
|
12.08.26 - 13:06
|
Strategic Education, Inc. and Leading Education Investors Seek Edtech Innovators for Second Signal Labs Cohort (Business Wire)
|
|
|
Testing, Measuring and Scaling Underway for First CohortHERNDON, Va.--(BUSINESS WIRE)--Strategic Education, Inc. (NASDAQ: STRA), a global leader in higher education and workforce development, today issued a call for applications for the second cohort of Strategic Education, Inc. Signal Labs (“Signal Labs”), an edtech innovation and future of work commercial pilot program supported by LearnLaunch Fund + Accelerator, as well as new additions Rethink Capital Partners and New Markets Venture Partners. Designed to accelerate breakthrough solutions in learning and employment, Signal Labs connects promising startups with investors and education leaders while providing direct access to Strategic Education's global portfolio of students, institutions, employers, and education technology platforms for product testing, validation, and potential scale. Selected startups will get immediate visibility from all venture partners.
Joining LearnLaunch in support of Signal Labs are Rethink Capital Partners and New Mark...
|
|
|
|
|
|
|
12.08.26 - 12:03
|
Amcor Reports Strong Fourth Quarter and Full-Year Results (PR Newswire)
|
|
|
ZURICH, Aug. 12, 2026 /PRNewswire/ -- Highlights - Three Months Ended June 30, 2026 Net sales $6.4 billion, up 26% largely driven by Berry acquisition and pass through of higher raw material costs Net income $389 million vs. -$39 million prior-year Adjusted EBITDA $1,045 million vs. $789......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.08.26 - 13:06
|
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates (Business Wire)
|
|
|
Continued to advance the development of three late-stage programs, supported by the Prolaio platform, aimed at addressing cardiovascular diseases where no approved treatments exist
Danicamtiv KINSHIP-DCM Phase 3 Cohort 1 enrollment now underway; Phase 2b topline data expected 1H 2027
Strong cash position of $661 million following recent IPO extends runway through multiple data readouts and initiation of Phase 3 clinical trialsSOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--$KARD #CVD--Kardigan™, Inc. (Nasdaq: KARD) (“Kardigan” or “the Company”), a clinical-stage precision therapeutics company developing medicines that target the root causes of cardiovascular diseases with no approved treatments, today reported financial results from the second quarter ended June 30, 2026, and provided recent business updates.
“Our IPO has positioned Kardigan to advance a portfolio of late-stage cardiovascular programs to address diseases where patients urgently need better treatment options,”...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
